Key Events This Week
4 May: Week opens at Rs.518.40
5 May: Rating upgraded to Sell on technical improvements
6 May: Technical momentum shifts amid mixed signals
8 May: Week closes at Rs.525.45 (+1.36%)
May 08
BSE+NSE Vol: 3.34 lacs
4 May: Week opens at Rs.518.40
5 May: Rating upgraded to Sell on technical improvements
6 May: Technical momentum shifts amid mixed signals
8 May: Week closes at Rs.525.45 (+1.36%)

Solara Active Pharma Sciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by an improvement in technical indicators despite persistent fundamental challenges. The company’s technical trend has shifted from mildly bearish to sideways, prompting a reassessment of its outlook. However, weak financial performance and long-term profitability concerns continue to weigh on the stock’s prospects.
Read full news article
Solara Active Pharma Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock exhibits a complex interplay of bullish and bearish signals across key technical indicators, reflecting a nuanced market sentiment.
Read full news article
Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics discussed here represent the stock’s current position as of 25 April 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Solara Active Pharma Sciences Ltd has experienced a nuanced shift in its technical momentum, with recent indicators signalling a transition from bearish to mildly bearish territory. Despite a modest 2.81% gain on 9 Apr 2026, the stock’s broader technical landscape remains complex, reflecting mixed signals from key momentum and trend indicators.
Read full news article
30 Mar: New 52-week low at Rs.422.85 amid broad market weakness
01 Apr: Intraday high of Rs.459.85 with a 7.83% surge
02 Apr: Continued gains, closing at Rs.475.15 (+3.20%)
03 Apr: Week closes at Rs.475.15, up 7.28% for the week

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the stock’s current position as of 03 April 2026, providing investors with the latest comprehensive view.
Read full news article
The Sensex advanced 2.49% on 1 Apr 2026, yet Solara Active Pharma Sciences Ltd outpaced the broader market with a 7.83% gain, reaching an intraday high of Rs 459.85. This 6.23-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.07% rise signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news articleSolara Active Pharma Sciences has informed the exchange about the Press Release titled Solara is pleased to announce the successful completion of US FDA inspection of its Puducherry Facility with continued state of cGMP Compliance.
Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026
Solara Active Pharma Sciences Limited has informed the Exchange about the copy of Newspaper publication regarding the circulation of Second and Final Call Money Notice
No Upcoming Board Meetings
Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21
No Splits history available
No Bonus history available
Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24